1887

Abstract

A significant increase in carbapenem-resistance rates among isolates collected in two Turkish medical centres was detected in the 2000–2006 period (20–60 %) by the SENTRY Antimicrobial Surveillance Program. Carbapenem-resistant strains from 2006 were evaluated for the presence of encoding genes and epidemic clonality. OXA-58-like and OXA-23-like carbapenemase-producing strains were detected in both medical institutions. Seventeen out of 18 strains from Ankara were positive for primers and belonged to the same clone, whilst 26 isolates (25 from Istanbul and one from Ankara) harboured -like genes and showed identical or similar PFGE patterns. Isolates producing OXA-23-like carbapenemases were more resistant than OXA-58-like carbapenemase producers to non-carbapenem antimicrobial agents. Carbapenem resistance in these institutions was observed to be largely driven by the dissemination of clones producing OXA-type carbapenemases.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.2008/002469-0
2008-12-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/12/1529.html?itemId=/content/journal/jmm/10.1099/jmm.0.2008/002469-0&mimeType=html&fmt=ahah

References

  1. Alp E., Esel D., Yildiz O., Voss A., Melchers W., Doganay M. 2006; Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital. Scand J Infect Dis 38:335–340 [CrossRef]
    [Google Scholar]
  2. Brown S., Amyes S. 2006; OXA β -lactamases in Acinetobacter : the story so far. J Antimicrob Chemother 57:1–3
    [Google Scholar]
  3. CLSI 2006 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically , 7th edn. Approved standard M7-A7 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  4. CLSI 2008 Performance Standards for Antimicrobial Susceptibility Testing ; 18th informational supplement, M100-S18 Wayne, PA: Clinical and Laboratory Standards Institute;
    [Google Scholar]
  5. Corvec S., Poirel L., Naas T., Drugeon H., Nordmann P. 2007; Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene bla OXA-23 in Acinetobacter baumannii . Antimicrob Agents Chemother 51:1530–1533 [CrossRef]
    [Google Scholar]
  6. Marque S., Poirel L., Heritier C., Brisse S., Blasco M. D., Filip R., Coman G., Naas T., Nordmann P. 2005; Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol 43:4885–4888 [CrossRef]
    [Google Scholar]
  7. Perez F., Hujer A. M., Hujer K. M., Decker B. K., Rather P. N., Bonomo R. A. 2007; Global challenge of multidrug-resistant Acinetobacter baumannii . Antimicrob Agents Chemother 51:3471–3484 [CrossRef]
    [Google Scholar]
  8. Poirel L., Nordmann P. 2006; Carbapenem resistance in Acinetobacter baumannii : mechanisms and epidemiology. Clin Microbiol Infect 12:826–836 [CrossRef]
    [Google Scholar]
  9. Poirel L., Pitout J. D., Nordmann P. 2007; Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2:501–512 [CrossRef]
    [Google Scholar]
  10. Segal H., Jacobson R. K., Garny S., Bamford C. M., Elisha B. G. 2007; Extended −10 promoter in IS Aba-1 upstream of bla OXA-23 from Acinetobacter baumannii . Antimicrob Agents Chemother 51:3040–3041 [CrossRef]
    [Google Scholar]
  11. Vahaboglu H., Budak F., Kasap M., Gacar G., Torol S., Karadenizli A., Kolayli F., Eroglu C. 2006; High prevalence of OXA-51-type class D β -lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. J Antimicrob Chemother 58:537–542 [CrossRef]
    [Google Scholar]
  12. Woodford N., Ellington M. J., Coelho J. M., Turton J. F., Ward M. E., Brown S., Amyes S. G., Livermore D. M. 2006; Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27:351–353 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.2008/002469-0
Loading
/content/journal/jmm/10.1099/jmm.0.2008/002469-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error